Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Why Rover Group Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Published 02/08/2023, 13:13
Updated 02/08/2023, 14:40
© Reuters. Why Rover Group Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares surged 52.1% to $0.1049 in pre-market trading.
  • Rubicon Technologies, Inc. (NYSE: RBT) rose 29.5% to $1.58 in pre-market trading after gaining 40% on Tuesday. Rubicon Technologies is expected to release its second quarter 2023 financial results on Aug. 8, 2023.
  • Rover Group, Inc. (NASDAQ: ROVR) gained 20.6% to $6.73 in pre-market trading after the company reported better-than-expected second-quarter results.
  • e.l.f. Beauty, Inc. (NYSE: ELF) shares gained 18.6% to $138.21 in pre-market trading after the company reported better-than-expected first-quarter results.
  • Cardlytics, Inc. (NASDAQ: CDLX) shares rose 18.6% to $13.37 in pre-market trading after posting upbeat quarterly results.
  • Freshworks Inc. (NASDAQ: FRSH) shares gained 16.3% to $21.21 in pre-market trading after the company reported better-than-expected second-quarter results.
  • Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) shares climbed 16.1% to $6.48 in pre-market trading. Creative Medical Technology regained compliance with Nasdaq listing requirements.
  • Better Therapeutics, Inc. (NASDAQ: BTTX) rose 10.8% to $0.7980 in pre-market trading. Better Therapeutics recently announced $6.7 million in new financing at an average price of $0.77 per share.
  • Aurora Acquisition Corp. (NASDAQ: AURC) shares rose 10.4% to $34.21 in pre-market trading after declining around 33% on Tuesday.
  • Match Group, Inc. (NASDAQ: MTCH) gained 10.2% to $50.85 in pre-market trading after the company reported better-than-expected second-quarter results and above-consensus third-quarter revenue outlook.
Losers
  • Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) fell 42.6% to $2.29 in pre-market trading possibly on profit taking after the stock rallied roughly 180% on Tuesday.
  • Aptevo Therapeutics Inc. (NASDAQ: APVO) shares fell 35.7% to $0.63 in pre-market trading after the company priced $5 million public offering of 8,064,517 shares at $0.62 per share.
  • Cambium Networks Corporation (NASDAQ: CMBM) fell 29% to $11.55 in pre-market trading after the company reported worse-than-expected second-quarter results.
  • Femasys Inc. (NASDAQ: FEMY) fell 21.7% to $0.4614 in pre-market trading after gaining 4% on Tuesday.
  • Mobile Global Esports Inc. (NASDAQ: MGAM) fell 20.2% to $0.67 in pre-market trading after jumping 64% on Tuesday.
  • trivago N.V. (NASDAQ: TRVG) fell 14.2% to $1.15 in pre-market trading after the company posted weaker-than-expected second-quarter results.
  • Forward Industries, Inc. (NASDAQ: FORD) shares fell 13.6% to $0.76 in pre-market trading.
  • SolarEdge Technologies, Inc. (NASDAQ: SEDG) fell 13.1% to $208.00 in pre-market after the company posted second-quarter results and issued weak third-quarter guidance.
  • TMC the metals company Inc. (NASDAQ: TMC) fell 12.2% to $1.38 in pre-market trading after the company issued corporate update on expected timeline, application costs and production capacity following part II Of the 28th session of the International Seabed Authority.
  • Sprouts Farmers Market, Inc. (NASDAQ: SFM) shares fell 11% to $34.05 in pre-market trading after the company posted second-quarter results and announced retirement of CFO Lawrence Molloy.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Starbucks, Phillips 66 And 3 Stocks To Watch Heading Into Wednesday

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.